• Telesis Bio Announces Commercial Release of Cell-free Amplification Kit for Generation of ... 11/6/2023
• Telesis Bio Announces Commercial Release of BioXp® NGS Library Prep Kit for WGS 10/3/2023
• Telesis Bio Appoints William J. Kullback Chief Financial Officer 8/31/2023
• Telesis Bio to Present at Jefferies Healthcare Conference 2023 6/9/2023
• Telesis Bio to Present at Antibody Engineering and Therapeutics, Europe 2023 6/6/2023
• Telesis Bio Secures Financing of $28.0 Million 6/2/2023
• Telesis Bio Announces First Commercial Shipment of BioXp® NGS Library Prep Kit 5/19/2023
• Telesis Bio to Present at Protein Engineering Summit (PEGS Boston 2023) 5/16/2023
• Telesis Bio Releases BioXp® Select Kits to Enable DNA Amplification and Scale-up 4/3/2023